I have been on ADT continuously since February 2016 and in general I have tolerated Lupron (in my case) fairly well. The hot flashes have diminished in frequency and intensity over time. I have found that exercise, keeping cool by not over dressing and maintaining a positive state of mind have helped. Recently, though, I started experiencing more periods of brain fog, more difficulty with concentration, staying on task and retaining information. This was a cause for concern because I felt that these symptoms would compromise my QOL and importantly my ability to follow and stay on top of the literature on PCa.
Shortly after diagnosis I obtained a prescription for medical marijuana to improve appetite, reduce anxiety and for what I thought at the time were potential anti-cancer benefits; and CBD was reputed to help prevent or reduce neuropathy at the extremities during chemotherapy (I had none at 300 mf of CBD). I have since come to the conclusion that THC and CBD have little anti-cancer effect because it is difficult to achieve a potentially therapeutic concentration in the blood for either compound due to rapid metabolism by the liver, and in the case of THC no one wants to be stoned 24 hours a day (with the exception of perhaps a few).
Last year I came across an interesting paper in Nature Medicine which described the effects of low dose THC on the development and function of young and old mouse brains. Low dosages of THC impaired the development and function of young brains (a good reason to prevent teenagers from over using marijuana), but improved the cognitive function of older mice to a level equivalent to younger mice.
“A chronic low dose of Δ9-tetrahydrocannabinol (THC) restores cognitive function in old mice”
ncbi.nlm.nih.gov/pubmed/284...
This paper inspired me to run an informal trial to see if low dose THC improves cognitive function in humans. I had some THC left over from previous use so for the last month I have been taking 0.15 ml of a 25 mg/ml THC in a medium chain triglyceride oil (=3.75 mg/ml) every other day at bedtime (only) and have found the following:
1. Better quality of sleep, even on off days
2. Better concentration and time on task
3. Less anxious, more relaxed
4. No apparent brain fog
5. Better memory recall
It should be noted that a concentration of 3.75 mg/d is significantly lower than the dosage used in the aforementioned paper (when converted to equivalent human dosages).
I believe it would be useful to run a formal trial comparing four groups of men on ADT, one group would be the control group and the other three groups would take 2, 4 and 6 mg per day, respectively, at bedtime. The trials would include self reporting, filling out questionnaires and recognized cognition tests. Perhaps researchers who have an interest in ADT and its side effects may be interested in conducting such a trial. If members of this forum know of doctors in the field, please forward their names.
Cheers,
Philip
P.S. I purposely, substituted smog for fog